Researchers aimed to develop a stratification method to evaluate symptom prevalence and distinct treatment responses in patients with Sjogren syndrome.
A recent study indicated that among participants with rheumatoid arthritis, all autoantibodies followed a similar trajectory, with an early initial elevation, a period of stability, and an immediate increase pre-RA diagnosis.
Pain, body mass index, age, sex, and Kellgren-Lawrence grade were significantly associated with uCTX-II levels.
Investigators prospectively evaluated the efficacy, general safety, and joint safety of fasinumab in patients with hip and/or knee pain in osteoarthritis.
Researchers evaluated the outcomes of patients with immune checkpoint inhibitor-induced inflammatory arthritis and assessed the risk factors for long-term disease requiring immunomodulatory treatment.
Investigators found data that showed similar efficacy for intravenous golimumab rates across age groups in patients with active rheumatoid arthritis.
Researchers conducted this study to determine whether bone bridge formation was correlated with low bone mineral density in patients with ankylosing spondylitis.
Researchers investigated the safety and efficacy of twice-weekly 28.2 μg teriparatide compared with once-weekly 56.5 μg teriparatide in Japanese patients with osteoporosis.
For postmenopausal women with osteoporosis, combined treatment with teriparatide 40 μg and denosumab can increase spine and hip bone mineral density more significantly than standard combination therapy.
